Cintas saw a positive improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 70 to 73.
IBD's unique RS Rating tracks technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an RS Rating north of 80 as they launch their biggest price moves. See if Cintas can continue to show renewed price strength and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Cintas is working on a consolidation with a 228.12 buy point. See if the stock can break out in heavy trade.
Cintas saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 18% to 21%. Revenue rose from 7% to 8%. Look for the next report on or around Mar. 20.
Cintas earns the No. 6 rank among its peers in the Commercial Services-Outsourcing industry group. HealthEquity, ExlService Holdings and Red Violet are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
